Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
Br J Dermatol
.
2020 Jan;182(1):227-229.
doi: 10.1111/bjd.18264.
Epub 2019 Sep 5.
Authors
R Laufer Britva
1
2
3
,
A Keren
1
2
,
R Paus
4
5
,
A Gilhar
1
2
Affiliations
1
Skin Research Laboratory, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
2
Rambam Health Care Campus, Haifa, Israel.
3
Department of Dermatology, Rambam Health Care Campus, Haifa, Israel.
4
Dr. Philipp Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
5
Centre for Dermatology Research, University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester, U.K.
PMID:
31254391
DOI:
10.1111/bjd.18264
No abstract available
Publication types
Letter
MeSH terms
Alopecia Areata* / drug therapy
Animals
Mice
Piperidines
Pyrimidines
Pyrroles
Thalidomide / analogs & derivatives
Substances
Piperidines
Pyrimidines
Pyrroles
Thalidomide
tofacitinib
apremilast